Aim: Arterial stiffness has been reported to correlate with cardiovascular disease (CVD). Brachialankle pulse wave velocity (baPWV) is easy to measure and has been used as a marker to evaluate arterial stiffness. The objective of the present study was to determine the cut-off value of baPWV for predicting cardiovascular prognosis in a prospective cohort study. Methods: Four hundred forty patients with essential hypertension were analyzed in study 1 with a mean follow-up of 6.3±0.1 years. Four hundred patients from study 1 who did not have a past history of CVD and/or stroke were analyzed in study 2 with a mean follow-up of 6.4±0.1 years. Stroke, CVD, and death were the primary endpoints. Results: Receiver operating characteristic (ROC) curve analysis revealed that 1750.0 cm/sec is an appropriate cut-off value for baPWV to predict the onset of stroke, CVD, stroke＋CVD, and total mortality (area under curve: 0.576-0.719). A baPWV higher than 1750.0 may also be a significant and independent risk factor for the onset of CVD＋stroke (relative risk: 2.048 (1.176-3.616), p= 0.0113 in study 1; relative risk: 1.920 (1.028-3.634), p = 0.0408 in study 2). Conclusions: The present study indicates that 1750.0 cm/sec could be a useful cut-off value for baPWV to predict cardiovascular prognosis. J Atheroscler Thromb, 2013; 20:391-400.
Introduction
Arterial stiffness is associated with hypertension 1) , and increased arterial stiffness has been correlated with the development of cardiovascular disease (CVD) [2] [3] [4] . Although various indexes for noninvasively evaluating arterial stiffness have been investigated, difficulties still exist when selecting the most appropriate methodology for clinical use 5) . One of the most established indexes for evaluating arterial stiffness is pulse wave velocity (PWV) 5) . Many researchers, including ourselves, have revealed a correlation between PWV and CVD using carotid-femoral PWV (cfPWV) as the representative PWV 6, 7) . The cfPWV is currently recognized as the most prevalent index for assessing arterial stiffness; however, the complexity of measuring cfPWV 8) prevents the expansion of cfPWV usage in routine clinical practice.
Recently, brachial-ankle PWV (baPWV) has become available in clinical settings. We can calculate baPWV easily and automatically using pressure cuffs on the brachial and tibial arteries. Many studies have investigated the clinical significance of baPWV 9, 10) , which has been revealed to correlate significantly with coronary artery disease 11) , declined renal function 12) , and total mortality 13) . We previously reported the clinical usefulness and limitations of baPWV 14, 15) , which has a close correlation with cfPWV 16) . Despite this evidence, the predictive value of baPWV for CVD is still controversial. For example, Yoshida et al. reported that baPWV does not predict CVD in patients with type 2 diabetes mellitus 17) ; however, limited studies included events related to hypertensive complications and cause of death. We also confirmed each patient's responses in detail by checking them against their medical records. The primary endpoint of this study was new onset of stroke (paralysis and diagnosis with computed tomography and/or MRI) or new onset of CVD, including angina pectoris (typical chest pain with ST segment changes on ECG), myocardial infarction (ST segmental elevation with a more than two-fold elevation of creatinine kinase), heart failure (diagnosed using American Heart Association criteria), and the rupture of an aortic aneurysm (diagnosed employing ultrasound echography or computed tomography). The follow-up duration was considered to include the interval from the initial evaluation to the time of event onset or September 2010. The average follow-up period was 6.3±0.1 years in study 1 and 6.4±0.1 years in study 2.
Blood Pressure Measurements
Conventional blood pressure (BP) was measured by trained observers with an electronic sphygmomanometer (HEM-705IT or HEM-711, OMRON). Following the guidelines for the management of hypertension, clinical BP was measured at least two times in the sitting position after a 5 min rest, and we adopted the average of two readings as the office BP if the difference between measured values was less than 5 mmHg. When the difference between measured values was more than 5 mmHg, additional measurements were taken to obtain stable BP readings and the average of the two stable readings was taken as the office have reported the cut-off value for baPWV to predict cardiovascular prognosis. To extend the clinical usefulness of baPWV, we need to obtain an appropriate cutoff value of baPWV to manage hypertensive patients.
Therefore, the objective of the present study was to determine the cut-off value of baPWV for predicting stroke, CVD, and total mortality by analyzing a prospective cohort. We also aimed to establish the significance of baPWV in CVDs using the cut-off value obtained.
Methods

Study Subjects and Study Design
The present hospital-based cohort study was designed as a part of the NOn-invasive Atherosclerotic evaluation of Hypertension (NOAH) study 7) of 813 serial outpatients diagnosed with essential hypertension, who were sequentially recruited between January 1998 and June 2004 at Osaka University Medical Hospital. We included subjects who had undergone echocardiography, electrocardiogram (ECG), brain magnetic resonance imaging (MRI), and carotid ultrasonography. We excluded subjects with an ABI ＜0.9, who had suffered a cerebrovascular or cardiovascular event within 1 month, had atrial fibrillation, or who had congestive heart failure grade 3 or higher on the New York Heart Association scale. Fig. 1 is a flow chart of the selection process for study subjects. The baPWV was available for 488 of the 813 NOAH study subjects. Twenty-four subjects failed to follow up and 24 subjects had an ABI ＜0.9. Thus, 440 outpatients were analyzed in study 1. As 40 subjects had a past history of CVD and/or stroke, we analyzed 400 subjects without a past history of CVD and/or stroke in study 2. Patients with diabetes mellitus were diagnosed according to the criteria of the American Diabetes Association: fasting plasma glucose ≥ 126 mg/dL, HbA1c ≥ 6.5%, a two-hour value in an oral glucose tolerance test ≥ 200 mg/dL, a random plasma glucose concentration ≥ 200 mg/dL in the presence of symptoms, or taking drugs for diabetes. Patients with hyperlipidemia were diagnosed based on total cholesterol ≥ 220 mg/dL, LDL cholesterol ≥ 140 mg/dL, triglyceride ≥ 150 mg/dL, or taking drugs for hyperlipidemia. The study protocol was approved by the hospital ethics committee, and written informed consent was obtained from all participants.
Follow-Up Evaluation
We conducted the clinical follow-up with clinical visits, mailed questionnaires, and telephone contact every September from 2003. The questionnaire Denshi Co.). Heart sounds were recorded simultaneously. A preprocessor automatically analyzed the gain in each waveform and adjusted it to ensure the equality of the two signals. This procedure was published in detail previously 18) . We measured the systolic BP of the brachial artery in the right arm and the posterior tibial artery in both ankles with the patients in a supine position, and ABI was calculated by dividing the systolic BP in the ankle by the systolic BP in the arm.
Because the baPWVs obtained on the right side and left side were identical (r = 0.83, p＜0.0001), we chose to use the right baPWV in the present study. A previous study reported that these automatic noninvasive measurements are accurate and require minimal technical skill, and it established the validity, reliability, and reproducibility of measuring PWV 9, 18) . The intra-observer coefficient of variation (CV) was calculated using three measurements each from seven healthy men. The intra-observer CV for baPWV was 3.4±1.8%.
BP.
Pulse Wave Velocity Measurement and Ankle Brachial Index
We evaluated baPWV as an indication of arterial stiffness. For the PWV measurements, participants visited the hospital in the morning; they were instructed not to take any antihypertensive drugs, nitrate, or aspirin for the eight hours preceding their visit. Measurements were performed with the patient in the supine position after 30 min of rest. The baPWV was measured in a controlled environment at 22±2 ℃. Three measurements taken two minutes apart were averaged.
We determined baPWV using a model FCP-4731 (Fukuda Denshi Co., Tokyo, Japan), which allowed on-line pulse wave recording and automatic calculation. The pulse waveforms of the right carotid artery and femoral arteries were recorded noninvasively using a TY-306-Fukuda pressure-sensitive transducer (Fukuda patients with higher and lower baPWV. An event-free curve was estimated using the Kaplan-Meier method.
The log-rank test was used to compare the differences in event-free rates between subjects with higher and lower baPWV. A Cox proportional hazard model was used to detect the relative risks of higher and lower baPWV on prognoses. Significance was set at p＜0.05. Table 1 provides the baseline clinical characteristics of the participants in the study. In study 1, 35
Results
Statistical Analysis
The data were analyzed using JMP ver. 9.0.1 (SAS, Cary, NC, USA) and are presented as the mean ±SEM. To compare the ability of baPWV measurements to classify subjects with various outcomes accurately, we evaluated the areas under the curve (AUCs) for receiver operating characteristic (ROC) analysis to obtain the cut-off value of baPWV that predicts prognoses. We determined the cut-off point as "the point with the shortest distance from the left upper corner of the graph". Analysis of variance and Student's t -test were used to test for significant differences between We also performed ROC analysis in study 2. Fig. 3 shows the ROC curves for stroke, CVD, stroke＋CVD, and total mortality in study 2.
strokes, 30 cases of CVD, 62 stroke＋CVD, and 26 deaths were recorded during a mean follow-up of 6.3 ±0.1 years. In study 2, 26 strokes, 25 cases of CVD, 48 stroke＋CVD, and 17 deaths were recorded during a mean follow-up of 6.4±0.1 years. No significant difference was found in the characteristics between the subjects in study 1 and the subjects in study 2. First, we performed ROC analysis to obtain the cut-off value of baPWV for predicting stroke, CVD, and death. Fig. 2 shows the ROC curves for stroke, CVD, stroke＋CVD, and total mortality in study 1. These ROC curves revealed that 1736.0 cm/sec was stroke＋CVD after adjusting for traditional risk factors (i.e., age, sex, diabetes mellitus, dyslipidemia, and current smoking) and the use of antihypertensive agents (relative risk: 2.048, p = 0.0113 in study 1; relative risk: 1.920, p = 0.0408 in study 2; Table 3 ).
Discussion
In the present prospective cohort study, we found that 1750.0 cm/sec is an appropriate baPWV cut-off value for predicting the onset of stroke, CVD, stroke ＋CVD, and total mortality in overall subjects and subjects without a past history of stroke and/or CVD. The Cox proportional hazard model also suggested that a baPWV higher than 1750.0 cm/sec may be a significant and independent risk factor for the onset of stroke＋CVD.
To the best of our knowledge, this study is the first to determine the cut-off value of baPWV for prepertensive agents (ARBs, ACEIs, CCBs, diuretics, alpha blockers, and beta blockers) or the usage of statins between subjects with higher and lower baPWV.
Next, we conducted Kaplan-Meier analysis and the log-rank test to investigate the correlation between baPWV and prognoses. In study 1, using 1750.0 cm/ sec as the cut-off value, we found that subjects with higher baPWV had a significantly higher incidence of stroke (p = 0.0176), CVD (p = 0.0269), stroke＋CVD (p = 0.0005), and death (p = 0.0076, Fig. 4) . Similarly, in study 2, we found that subjects with higher baPWV had a significantly higher incidence of stroke (p= 0.0420), stroke＋CVD (p = 0.0090), and death (p = 0.0042). On the other hand, no significant difference was found in the incidence of CVD (p= 0.0999, Fig. 5) .
Finally, the Cox proportional hazard model showed that baPWV is a significant risk factor for Patients with higher baPWV (cut-off: 1750.0) had a significantly higher incidence of stroke, CVD, stroke＋CVD, and total mortality.
A C B D value in our study. In theory, baPWV reflects both central arterial stiffness and peripheral arterial stiffness; on the other hand, cfPWV reflects mainly central arterial stiffness. As the association between central arterial stiffness and CVD is well established 22) , cfPWV has become one of the most prevalent indexes for assessing arterial stiffness and predicting cardiovascular prognosis; however, proficient skills are needed to measure cfPWV. In contrast, baPWV is easy and convenient to measure and does not require proficient skills. Thus, baPWV has gradually come into clinical use. Many studies have reported the association between baPWV and CVD [11] [12] [13] [14] [15] ; therefore, our results of the cut-off value of baPWV for predicting cardiovascular prognosis could extend the usefulness of baPWV to the management of hypertensive patients in clinical settings.
The present clinical guidelines for the management of hypertension recommend the stratification of dicting various cardiovascular prognoses in patients with essential hypertension. Previous studies have reported the cut-off value of baPWV under more limited clinical conditions. For example, Tomiyama et al. suggested that, in patients with acute coronary syndrome, a baPWV of 1700 cm/sec can predict posthospitalization cardiovascular events and 1800 cm/sec can predict major cardiovascular events 19) . This result seems to coincide well with the baPWV cut-off value revealed in the present study. Miyano et al. reported that, in elderly people (mean age: 76 years), a baPWV of 1963 cm/sec can be the cut-off for predicting total mortality or cardiovascular mortality 20) . Because arterial stiffness is well known to increase with age 21) , older subjects have a higher baPWV. Our results also confirmed that baPWV significantly correlates with age (p＜0.0001), which might be why the cut-off value of baPWV that Miyano et al. reported in their study of elderly subjects was higher than the cut-off Patients with higher baPWV (cut-off: 1750.0) had a significantly higher incidence of stroke, stroke＋ CVD, and total mortality.
A C B D subjects with white coat hypertension might have a higher systolic BP in the hospital, and thus higher baPWV.
In conclusion, the present study revealed that 1750.0 cm/sec is an appropriate baPWV cut-off value for predicting the onset of stroke, CVD, stroke＋ CVD, and total mortality. Our study also revealed that baPWV ＞1750.0 cm/sec may be a significant and independent risk factor for the onset of CVD＋stroke.
hypertensive patients according to risk factors, such as diabetes mellitus, metabolic syndrome, CKD, organ damage, and CVD. Previous studies reported that increased arterial stiffness is correlated with the development of CVD [2] [3] [4] ; thus, evaluating arterial stiffness could be important for preventing CVD. Because various factors influence the incidence of cardiovascular events, the ability of baPWV to predict cardiovascular events is not high (AUCs were small and indicated low accuracy), but the present study showed that a baPWV of 1750.0 can be used as a cut-off value to stratify hypertensive patients easily and accurately for the risk of arterial stiffness independent of other risk factors. Thus, we could provide more adequate treatment to each patient by evaluating baPWV in addition to traditional risk factors.
The present study has several limitations. First, this study utilized a hospital-based cohort that was relatively small. We need larger cohort studies and multicenter trials to avoid study bias. As few subjects had stroke or CVD, we could not show the clinical impact of baPWV on the onset of CVD or stroke. Second, this study was conducted at a university hospital, and many study subjects had taken various drugs at the time of enrollment, including ARBs, ACEIs, and statins. Although no significant differences were found in the use of various classes of antihypertensive agents or statins between subjects with higher and lower baPWV, these medications might contribute to better outcomes, lower baPWV, and lower AUC in ROC analysis. Third, because this study was started in January 1998, when the toe brachial index (TBI), which is now known to be more reliable for the diagnosis of peripheral artery disease (PAD), was not widely used in clinical conditions, we only used the ABI to exclude subjects with PAD. Finally, because the measurement of baPWV using an automatic waveform analyzer is closely dependent on the systolic BP, our results could have been affected by this correlation. For example, 
